CorMedix Inc.

CRMD

$11.77

Name : CorMedix Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $926,953,152.00

EPSttm : 2.21

CorMedix Inc.

$11.77

5.73%

$0.715

Float Short %

24.38

Margin Of Safety %

Put/Call OI Ratio

0.41

EPS Next Q Diff

0.15

EPS Last/This Y

2.94

EPS This/Next Y

-0.13

Price

12.49

Target Price

Analyst Recom

Performance Q

7.31

Relative Volume

0.84

Beta

1.37

Ticker: CRMD

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-01	CRMD	9.81	0.28	0.13	52374
2025-12-02	CRMD	9.78	0.28	0.18	52549
2025-12-03	CRMD	10.32	0.28	0.61	53085
2025-12-04	CRMD	10.65	0.28	0.34	54031
2025-12-05	CRMD	10.56	0.28	0.10	54475
2025-12-08	CRMD	11.27	0.28	0.46	54520
2025-12-09	CRMD	11.61	0.30	0.25	55567
2025-12-10	CRMD	11.46	0.31	0.11	61793
2025-12-11	CRMD	11.73	0.32	0.30	61043
2025-12-12	CRMD	11.49	0.32	0.11	61506
2025-12-15	CRMD	11.33	0.32	0.05	61696
2025-12-16	CRMD	11.43	0.31	0.12	62870
2025-12-17	CRMD	11.45	0.31	0.32	63197
2025-12-18	CRMD	11.91	0.31	0.21	63280
2025-12-19	CRMD	12.02	0.32	0.55	65386
2025-12-22	CRMD	12.39	0.40	0.42	44841
2025-12-23	CRMD	11.98	0.41	1.02	49602
2025-12-26	CRMD	12.53	0.41	0.41	51892
2025-12-29	CRMD	12.74	0.41	0.36	53104
2025-12-30	CRMD	12.49	0.41	0.30	53793
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-01	CRMD	9.81	218.2	-	2.63
2025-12-02	CRMD	9.78	218.2	-	2.63
2025-12-03	CRMD	10.32	218.2	-	2.63
2025-12-04	CRMD	10.65	218.2	-	2.63
2025-12-05	CRMD	10.56	218.2	-	2.63
2025-12-08	CRMD	11.26	218.2	-	2.63
2025-12-09	CRMD	11.62	218.2	-	2.63
2025-12-10	CRMD	11.62	218.2	-	2.63
2025-12-11	CRMD	11.74	218.2	-	2.63
2025-12-12	CRMD	11.49	218.2	-	2.63
2025-12-15	CRMD	11.33	218.2	-	2.63
2025-12-16	CRMD	11.33	218.2	-	2.63
2025-12-17	CRMD	11.46	218.2	-	2.63
2025-12-18	CRMD	11.92	218.2	-	2.63
2025-12-19	CRMD	12.02	218.2	-	2.63
2025-12-22	CRMD	12.48	218.2	-	2.63
2025-12-23	CRMD	11.98	218.2	-	2.63
2025-12-26	CRMD	12.54	218.2	-	2.63
2025-12-29	CRMD	12.75	218.2	-	2.63
2025-12-30	CRMD	12.49	218.2	-	2.63
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-01	CRMD	-2.03	13.40	25.16
2025-12-02	CRMD	-2.03	13.40	25.16
2025-12-03	CRMD	-2.03	13.40	25.16
2025-12-04	CRMD	-2.03	13.40	25.16
2025-12-05	CRMD	-2.50	13.40	25.16
2025-12-08	CRMD	-2.50	12.58	25.16
2025-12-09	CRMD	-2.50	12.58	25.16
2025-12-10	CRMD	-2.50	12.58	24.63
2025-12-11	CRMD	-3.24	12.58	24.63
2025-12-12	CRMD	-3.24	12.58	24.63
2025-12-15	CRMD	-3.24	12.56	24.61
2025-12-16	CRMD	-3.26	12.56	24.60
2025-12-17	CRMD	-3.26	12.56	24.60
2025-12-18	CRMD	-3.26	12.56	24.60
2025-12-19	CRMD	-3.26	12.56	24.60
2025-12-22	CRMD	-3.56	12.56	24.60
2025-12-23	CRMD	-3.56	12.56	24.60
2025-12-26	CRMD	-3.56	12.56	24.38
2025-12-29	CRMD	-3.49	12.58	24.38
2025-12-30	CRMD	-3.49	12.58	24.38
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.57

Avg. EPS Est. Current Quarter

0.7

Avg. EPS Est. Next Quarter

0.72

Insider Transactions

-3.49

Institutional Transactions

12.58

Beta

1.37

Average Sales Estimate Current Quarter

127

Average Sales Estimate Next Quarter

127

Fair Value

13.86

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

33.6

Max Drawdown 5-Year %

-84.5

Target Price

P/E

6.08

Forward P/E

4.91

PEG

P/S

4.59

P/B

2.61

P/Free Cash Flow

13.21

EPS

2.05

Average EPS Est. Cur. Y

2.63

EPS Next Y. (Est.)

2.5

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

75.83

Relative Volume

0.84

Return on Equity vs Sector %

16.1

Return on Equity vs Industry %

31.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

CorMedix Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 64

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

stock quote shares CRMD – CorMedix Inc. Stock Price stock today

news today CRMD – CorMedix Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CRMD – CorMedix Inc. yahoo finance google finance

stock history CRMD – CorMedix Inc. invest stock market

stock prices CRMD premarket after hours

ticker CRMD fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CRMD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y